Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$OTIC https://simplywall.st/news/2017/08/30/is-there-now-an-opportunity-in-otonomy-inc-otic/
Is There Now An Opportunity In Otonomy Inc (OTIC)?
Simply Wall St - 12h ago
Otonomy Inc (NASDAQ:OTIC), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqGS.
Nice bounce after hour trade
OTIC Chart
Bounce Time!
https://stockcharts.com/c-sc/sc?s=otic&p=D&yr=0&mn=7&dy=0&i=p42953174086&a=212213335&r=1335338504616">https://stockcharts.com/c-sc/sc?s=otic&p=D&yr=0&mn=7&dy=0&i=p42953174086&a=212213335&r=1335338504616" />
$OTIC Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
Federated Kaufmann Fund 2,221,901 Jan 30, 2017 7.34% 31,217,709
Prudential Jennison Small Company Fd 1,236,094 May 30, 2017 4.09% 14,956,737
Prudential Jennison Health Sciences Fd 889,099 May 30, 2017 2.94% 10,758,098
Vanguard Total Stock Market Index Fund 525,174 Mar 30, 2017 1.74% 6,695,968
iShares Russell 2000 ETF 436,555 May 30, 2017 1.44% 5,282,315
Fidelity Small Cap Stock Fund 392,000 Apr 29, 2017 1.30% 5,350,799
iShares NASDAQ Biotechnology ETF 392,459 May 30, 2017 1.30% 4,748,754
Federated Kaufmann Small Cap Fund 377,000 Jan 30, 2017 1.25% 5,296,850
Fidelity Small Cap Growth Fund 338,029 Apr 29, 2017 1.12% 4,614,095
Vanguard Extended Market Index Fund 330,835 Mar 30, 2017 1.09% 4,218,146
https://finance.yahoo.com/quote/OTIC/holders?p=OTIC
$OTIC Top Institutional Holders
Holder Shares Date Reported % Out Value
Wellington Management Company, LLP 4,216,968 Jun 29, 2017 13.94% 77,803,062
Jennison Associates LLC 3,599,706 Jun 29, 2017 11.90% 66,414,578
Blackrock Inc. 2,324,077 Jun 29, 2017 7.68% 42,879,222
TPG Group Holdings (SBS) Advisors, Inc. 2,159,335 Jun 29, 2017 7.14% 39,839,732
Federated Investors, Inc. 1,791,700 Jun 29, 2017 5.92% 33,056,866
Orbimed Advisors LLC. 1,559,074 Jun 29, 2017 5.15% 28,764,916
Millennium Management LLC 1,041,854 Jun 29, 2017 3.44% 19,222,207
Vanguard Group, Inc. (The) 949,910 Jun 29, 2017 3.14% 17,525,840
Price (T.Rowe) Associates Inc 777,237 Jun 29, 2017 2.57% 14,340,023
FMR, LLC 730,214 Jun 29, 2017 2.41% 13,472,448
https://finance.yahoo.com/quote/OTIC/holders?p=OTIC
Excuse me- I'm wrong. It is trading below cash. Sorry. I had been doing a calculation what it would start '18 with.
I like the setup, reminds me of ARN A from years back - I think this is gonna turn out like that. Sorry I sold everything I had on that one.
I agree with your drift- but it is above cash
EB!!! Good to see ya bud!! Hope all is well. If ever there was a trader who could spot a bottom-bargain, it is you! Here's hoping for some gold just around the corner here!!!
OTIC!
Me too!!!$$$
OTIC 3.70 (down $17) - entered a medium position afterhours in this biobust on it's trial-fail.
Close to $5.00 netcash.
More trials in the pipeline.
Don't see pps breakdowns this extreme very often.
I'm seeing very lowrisk with potential yuge upside?
Hedge funds working hard here in the AH to keep this subdued. Don't know why cause it's gonna be hard to keep an 82% haircut hidden from the bargain hunters!
Exactly, that bounce was 150-200% and the two others I was in were more than that.
I'm here too...after UNXL bounce we hope to see the same story
Extremely oversold. Over reaction today. Which gave me opportunity to buy cheapies $$$
OTIC in 20.000 shares $3.55 for massive bounce like my UNXL 200% bottom bounce 2 days ago. Huge $150m Cash by only 30m o/s. tomorrow is see a monsta bounce coming. Just my opinion. OTIC will fire up $10 +× imho. extremly undervalued now.
The pressure is def tighter than tight. The pinch is going to fly once released. I don't get how they let that stuff happen either. Huge manipulation.
Completely agree. It's unreal!
Money to be made though. Here we go.
That's a bingo . SEC will only halt it when the price starts moving up to quickly .
HOW THE !@#$ CAN THEY TRADE MORE THAN THE OUTSTANDING IN (1) SINGLE DAY
31M O/S= http://finviz.com/quote.ashx?t=OTIC&ty=c&ta=1&p=d
41M VOLUME
AND STILL BE THIS LOW AND HAVE THIS MUCH PRESSURE
SMH
THATS ONE OF THE MAJOR PROBLEMS WITH THIS FREAKIN COUNTRY
THEY ALLOW FOR UNBELIEVABLE MANIPULATION IN THIS MARKET
SAD BUT TRUE~!
Nice buy. Easy gains $$$ coming
RSI Is begging to bounce, so oversold, Expect Claytrader to do a video for end of day.
Grabbed 10,0000 @ $3.59. 30 min RSI is at 8. Looks good EDO rush up imo
Too many traders in at the same price point looking for a run. It they start selling everyone's stop is going to get taken out causing a free fall on strong volume.
This may bounce but don't load a day trading account full of it... This dog can and may bite another set of investors. Those stops are a target for algos and they can manipulate those to get them to hit. Careful....on a heavy load like this.
Lot's of upside from here. Just gotta be a lil patient.
$5 - $8 short term.
$OTIC Our Story
In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor visits, he was diagnosed with Ménière’s disease and quickly experienced the limitations of available treatments. With his physician, Jeffrey Harris, M.D., Ph.D., chief of the division of otolaryngology-head and neck surgery at the University of California, San Diego, and several other experts in the field of otology, Dr. Lichter founded Otonomy to bring new treatment options to patients with otic (ear) disorders.
Our mission today remains the same – to develop and commercialize novel and best-in-class therapeutics to address the significant unmet medical needs in the emerging otology market.
To overcome many of the limitations of delivering drugs to the ear, we have developed a proprietary technology that is designed to deliver drug that is retained in the ear for an extended period of time following a single local administration, which we refer to as “sustained-exposure”. Utilizing this technology, we have advanced multiple product candidates into development and launched our first product, OTIPRIO® (ciprofloxacin otic suspension). OTIPRIO is a single-dose, physician-administered antibacterial and the first product approved by the FDA for the treatment of pediatric patients with bilateral otitis media with effusion undergoing ear tube placement.
This looks like a bit of an overreaction
Very sweet looking chart there PP!! Thanks for offering that on OTIC.
Yup...just a matter of getting beyond today's volatility and all the beer flippers!
No need to defend poor trading decisions
$OTIC Book value is $5.60 per share 150 Million in Cash W no debt
I still made $500. Off to other positions
Wow you sold at 3.75? I think I bought your shares and now it's at 4.20
Thanks!
Followers
|
27
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
549
|
Created
|
12/27/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |